146 related articles for article (PubMed ID: 38420415)
1. A novel method for colposcopic shunting in HPV-positive women: Quantitative detection of HPV E7 oncoprotein.
Wang X; Zhang H; Chen L; Xu J; Qu P
Heliyon; 2024 Feb; 10(4):e25238. PubMed ID: 38420415
[TBL] [Abstract][Full Text] [Related]
2. HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome.
Wang X; Shuai G; Xu J; Liu M; Zhao J; Zhang N; Zhang W; Qu P
Front Oncol; 2023; 13():1221962. PubMed ID: 37795449
[TBL] [Abstract][Full Text] [Related]
3. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
4. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
Fan Y; Shen Z
Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of Different Testing Strategies Applied for Cervical Cancer Screening in Shuangliu District, Chengdu City].
Zeng X; Li J; Kang LN; Yan LP; He Z; Liao GD; Xi MR; Chen MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):896-903. PubMed ID: 36224694
[TBL] [Abstract][Full Text] [Related]
9. Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.
Sun J; Yue Y; Li R; Sun Q; Hu C; Ge X; Guan Q
Am J Transl Res; 2021; 13(6):7312-7317. PubMed ID: 34306499
[TBL] [Abstract][Full Text] [Related]
10. High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion.
Valença JE; Gonçalves AK; Guerreiro da Silva ID; Eleutério Junior J; Tenório da Silva T; Bruneska D; Ximenes RA
Rev Bras Ginecol Obstet; 2016 Mar; 38(3):154-9. PubMed ID: 27022787
[TBL] [Abstract][Full Text] [Related]
11. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
[TBL] [Abstract][Full Text] [Related]
13. The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.
Liu J; Yang T; Hu Y; Ye C
J Virol Methods; 2021 Mar; 289():114014. PubMed ID: 33188806
[TBL] [Abstract][Full Text] [Related]
14. The Triaging Effect of the Human Papillomavirus 16/18 E7 Oncoprotein Assay in HPV 16/18-Positive Patients for High-Grade Cervical Intraepithelial Neoplasia Screening: A Cross-Sectional Study.
Xiao X; Cao Y; Bi K; Wang W; Yang J; Wang J; Li Y; Li C; Guan R; Zhang Y; Wang J; Song S; Zhu L; Shi H
J Womens Health (Larchmt); 2023 Oct; 32(10):1136-1141. PubMed ID: 37615520
[No Abstract] [Full Text] [Related]
15. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
[No Abstract] [Full Text] [Related]
16. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
[TBL] [Abstract][Full Text] [Related]
17. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of human papillomavirus E6/E7 mRNA for residue and recurrence after cervical conization].
Zhao H; Shao H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 41(6):606-11. PubMed ID: 27374445
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].
Zhao X; Cui Y; Jiang S; Meng Y; Liu A; Wei L; Liu T; Han H; Liu X; Liu F; Li Y
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3432-5. PubMed ID: 25622677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]